Cure8 research brief
Why This Matters
Extraintestinal manifestations (EIMs) can significantly affect people with IBD and may require multidisciplinary care. Knowing how often EIMs are documented and which patients are more likely to have them helps clinicians plan screening and referrals.
Who Should Pay Attention
Clinicians treating adult IBD patients (gastroenterologists, rheumatologists, dermatologists, ophthalmologists), researchers studying IBD extraintestinal manifestations or Latin American cohorts, and adult patients curious about EIM frequency.
Study Snapshot
What To Know
The study reviewed 162 adult IBD patients (majority ulcerative colitis) evaluated between 2020 and 2025. EIMs were predefined as articular, dermatologic, or ocular and were present in 16.7% overall (11.7% articular; 2.5% dermatologic; 2.5% ocular).
In an adjusted exploratory model, patients in the harmonized Montreal category 3 had higher odds of documented EIMs; the authors suggest this category might help flag patients for broader systemic and multidisciplinary assessment.
The report is a retrospective, single-center analysis from a tertiary referral hospital in Lima, Peru; findings describe documented EIMs in routine records rather than prospective systematic screening. The association with Montreal category 3 is exploratory and requires external validation before changing practice.
Keep In Mind
Retrospective single-center design using documented clinical records; EIMs were predefined and capture depends on clinical documentation. The reported association with Montreal category 3 is exploratory and needs external validation.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.